In message <[log in to unmask]>, David Alter M.D.
<[log in to unmask]> writes
>I am curious about other institutions pros and cons of offering, and utilization
>of, fetal fibronectin.
>
>David Alter, MD
>Fellow, Chemical Pathology
>William Beaumont Hospital
>Michigan
>
Our obststricians tried it and found it was a simple way to spend a lot
of money whilst not altering clinical management one bit.
TIM
--
Prof. Tim Reynolds,
Professor of Chemical Pathology,
Queen's Hospital,
Burton-on-Trent,
UK.
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|